Titan Pharmaceuticals Inc (TTNP)
3.92
-0.11
(-2.73%)
USD |
NASDAQ |
Nov 05, 09:31
Titan Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0661 |
| December 31, 2020 | 0.1866 |
| September 30, 2020 | -5.708 |
| June 30, 2020 | 3.185 |
| March 31, 2020 | 0.7898 |
| December 31, 2019 | 2.805 |
| September 30, 2019 | -1.456 |
| June 30, 2019 | -7.060 |
| March 31, 2019 | 1.463 |
| December 31, 2018 | 0.6315 |
| September 30, 2018 | 0.7553 |
| June 30, 2018 | -2.697 |
| March 31, 2018 | -4.040 |
| December 31, 2017 | 7.683 |
| September 30, 2017 | 1.665 |
| June 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.8202 |
| December 31, 2012 | -0.5128 |
| September 30, 2012 | -0.4466 |
| June 30, 2012 | -0.5289 |
| March 31, 2012 | -0.5154 |
| December 31, 2011 | -0.6102 |
| September 30, 2011 | -0.855 |
| June 30, 2011 | -0.8546 |
| March 31, 2011 | -0.6994 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-5.708
Minimum
Sep 2020
3.185
Maximum
Jun 2020
0.0883
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.4322 |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 0.7145 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.35M |
| Total Liabilities (Quarterly) | 0.356M |
| Shareholders Equity (Quarterly) | 3.994M |